WASHINGTON (dpa-AFX) - AcelRx Pharmaceuticals Inc.'s (ACRX) New Drug
Application, submitted under section 505(b)(2), for DSUVIA for the treatment of
patients with moderate-to-severe acute pain in a medically supervised setting
JERUSALEM (dpa-AFX) - The following are some of the biotech stocks that made
their way onto the Day's Gainers & Losers' list of February 27, 2017.
1. HTG Molecular Diagnostics Inc. (HTGM)
Gained 158.54% to close Monday's...
The capriciousness associated with the biotech space is in the forefront once again with the near doubling in the shares of La Jolla Pharmaceutical Company (NASDAQ: LJPC) on Monday. The shares were on a high in reaction to positive trial...
Toward the end of trading Monday, the Dow traded up 0.03 percent to 20,827.15 while the NASDAQ gained 0.09 percent to 5,850.48. The S&P also rose, gaining 0.04 percent to 2,368.24.
Leading and Lagging Sectors
Basic material shares climbed by...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.